Single dose of MVA-BN vaccine offers 58% protection against mpox

Researchers confirm the effectiveness of the modified vaccinia Ankara-Bavarian Nordic vaccine against mpox.

Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD

LAS VEGAS — In patients with inflammatory bowel disease who lost response after infliximab (Remicade) induction, escalating the maintenance dose of the subcutaneous infliximab biosimilar

February 3, 2024

How an immunological Trojan horse could treat disease

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

January 30, 2024

Biohaven’s $230M offering; Plus, three new PIPEs

Read on for news about Benitec Biopharma, Korro Bio, Zura Bio, Ocular Therapeutix and SK biopharmaceuticals: Biohaven to seek $230M public offering: The company’s offering

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.